Home  /  Resource Library  /  Overall Survival Improved After Fewer Chemotherapy Cycles in Advanced Hodgkin Lymphoma: Long-Term Follow-Up of GHSG HD18 Trial

Overall Survival Improved After Fewer Chemotherapy Cycles in Advanced Hodgkin Lymphoma: Long-Term Follow-Up of GHSG HD18 Trial

EHA 2020: Study compared survival patterns in patients with Hodgkin lymphoma based on response to treatment.